問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
CHANGHUA CHRISTIAN HOSPITAL
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2008-11-10 - 2012-11-30
Condition/Disease
Test Drug
Participate Sites5Sites
Terminated5Sites
2012-06-01 - 2017-03-31
Participate Sites3Sites
Terminated3Sites
2010-12-01 - 2014-04-01
Participate Sites6Sites
Terminated6Sites
2010-06-30 - 2013-12-30
2019-09-15 - 2024-01-30
Moderately to Severely Active Ulcerative Colitis
Etrasimod
Participate Sites7Sites
Recruiting6Sites
Terminated1Sites
2021-03-31 - 2027-06-30
Participate Sites15Sites
Terminated15Sites
2021-02-26 - 2025-12-10
Recruiting5Sites
2020-05-01 - 2025-03-31
Chronic Hepatitis B Infection
RO7049389、RO7020531、Vemlidy韋立得、Viread 惠立妥、Baraclude 貝樂克
2022-06-01 - 2024-12-31
Participate Sites12Sites
Not yet recruiting4Sites
Recruiting8Sites
2021-12-01 - 2022-12-12
全部
